Advertisement
UK markets closed
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • FTSE 250

    19,884.73
    +74.07 (+0.37%)
     
  • AIM

    743.26
    +1.15 (+0.15%)
     
  • GBP/EUR

    1.1697
    +0.0004 (+0.03%)
     
  • GBP/USD

    1.2619
    -0.0003 (-0.03%)
     
  • Bitcoin GBP

    55,387.98
    -352.80 (-0.63%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • CAC 40

    8,205.81
    +1.00 (+0.01%)
     

EU drugs agency says no evidence ibuprofen worsens COVID-19

March 18 (Reuters) - The European Union's healthcare regulator on Wednesday said there currently is no evidence which links anti-inflammatory medicines such as ibuprofen with the worsening of COVID-19.

The European Medicines Agency (EMA) said https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19 it was monitoring the situation and said patients and healthcare professionals should consider all treatment options including paracetamol and anti-inflammatory drugs to treat fever or pain in patients with COVID-19.

The EMA's announcement follows a similar tone on Monday from Nurofen producer Reckitt Benckiser to check reports that said the pills' active ingredient ibuprofen would hurt patients. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Bernard Orr)